Consumer goods giant Reckitt posted a bump to revenue in the last financial year as its cost overhaul strategy to focus on specific divisions ramped up.
The blue-chip firm – which owns a massive portfolio of brands including Dettol, Durex, Lysol, Finish, Vanish, and Gaviscon – recorded a 5.2 per cent increase in revenue, driven by growth in China and other emerging markets.
Operating profit edged up two per cent to £3.5bn, whilst the firm’s profit margin swelled by nearly a quarter.
The Powerbrand Strategy and Future Growth
Reckitt’s focus on its “11 high-growth, high-margin powerbrands” – Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish, and Veet – is proving successful. Durex led the charge with 12.5 per cent revenue growth, fueled by innovations like Durex Intensity and portfolio upgrades. Dettol as well shone, becoming the firm’s largest powerbrand with 11 per cent growth.
This strategy signals a broader industry trend: companies are increasingly concentrating resources on their most profitable and recognizable brands to maximize returns and navigate economic uncertainty.
Emerging Markets as Key Growth Drivers
While North America and Europe experienced slower growth (0.2 per cent and a 1.4 per cent decline respectively), Reckitt’s success in emerging markets is noteworthy. Revenue in these regions surged 14.6 per cent, highlighting their importance as future growth engines. China and India were particularly strong performers, with a 10.7 per cent like-for-like revenue increase in Q1 2025.
This trend reflects the increasing purchasing power of consumers in developing economies and the growing demand for trusted consumer brands.
Cost Cutting and Efficiency Gains
Reckitt’s ‘Fuel for Growth’ programme, aimed at reducing fixed costs, is delivering results. Fixed costs were reduced to 19.4 per cent of net revenue in 2025, compared to around 21 per cent the previous year. The firm is targeting a fixed cost base below 19 per cent by the end of 2027.
This focus on efficiency is crucial in a challenging economic environment, allowing Reckitt to reinvest savings into its powerbrands and drive innovation.
Portfolio Optimization Through Divestitures
The completion of the Essential Home business sale in December 2025, generating a pre-tax profit gain of around £1.2bn, demonstrates Reckitt’s commitment to portfolio optimization. This move allows the company to focus on its core health and hygiene brands.
Similar divestitures are likely to continue across the consumer goods sector as companies streamline their operations and prioritize high-growth areas.
The Role of Innovation
Durex’s success with innovations like Durex Intensity underscores the importance of product development in driving growth. Continuous innovation is essential for maintaining market share and attracting new customers.
Expect to see further investment in research and development across Reckitt’s powerbrands, with a focus on meeting evolving consumer needs and preferences.
FAQ
- What are Reckitt’s powerbrands? Reckitt’s powerbrands are its 11 core brands: Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish, and Veet.
- Where is Reckitt seeing the most growth? Emerging markets, particularly China and India, are driving the most significant revenue growth for Reckitt.
- What is Reckitt doing to improve profitability? Reckitt is focusing on cost cutting, portfolio optimization through divestitures, and investing in its powerbrands.
Explore more insights into the consumer goods sector and market trends on City A.M. To stay informed about the latest developments.
